TriangleNCT00437034 · OUTCOME
Progression-free Survival (PFS)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Time from first treatment day until objective or symptomatic progression, assessed up to 6 months
What was measured
Assessed by Kaplan-Meier survival analysis and 95% confidence intervals will be calculated using Greenwood's formulae.
Analysis population: Data not collected
Groups in this outcome
Treatment (Antiangiogenesis Therapy)
Patients receive aflibercept IV over 1 hour on day 1. Treatment repeats every 2 weeks for up to 6 courses in the absence of disease progression or unacceptable toxicity. aflibercept: Given IV
| Group | Source count |
|---|---|
| Treatment (Antiangiogenesis Therapy) | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- Assessed by Kaplan-Meier survival analysis and 95% confidence intervals will be calculated using Greenwood's formulae.
- groups
- description
- Patients receive aflibercept IV over 1 hour on day 1. Treatment repeats every 2 weeks for up to 6 courses in the absence of disease progression or unacceptable toxicity. aflibercept: Given IV
- id
- OG000
- title
- Treatment (Antiangiogenesis Therapy)
- population Description
- Data not collected
- reporting Status
- POSTED
- time Frame
- Time from first treatment day until objective or symptomatic progression, assessed up to 6 months
- title
- Progression-free Survival (PFS)
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice